Skip to main content
Clinical Trials/EUCTR2020-001054-22-DK
EUCTR2020-001054-22-DK
Active, not recruiting
Phase 1

aparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block in Minimally Invasive Colon Surgery: A Randomized Controlled Multicentre Clinical Trial - OPMICS

Claus Anders Bertelsen0 sites360 target enrollmentMarch 25, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Claus Anders Bertelsen
Enrollment
360
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 25, 2020
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Claus Anders Bertelsen

Eligibility Criteria

Inclusion Criteria

  • \-Patients planned to receive curative elective minimally invasive colon surgery for colon cancer or adenoma without a planned ostomy. Colon cancer or adenoma is defined by a distance of more than 15 cm from the anal verge to the distal limitation of the tumour or adenoma as measured by rigid sigmoidoscope.
  • \-Age \= 18 years
  • \-Having given informed written consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 150
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 210

Exclusion Criteria

  • \-Known allergy to local analgesics
  • \-Known liver failure Class C according to the Child\-Pugh Score
  • \-Body weight of less than 40 kg
  • \-History of being a chronic pain patient (weekly intake WHO step II or step III or adjuvant step I analgesic)19
  • \-Presence of concomitant painful conditions other than low back pain that could confound the subject's trial assessments or self\-evaluation of the index pain, e.g., syndromes with widespread pain such as fibromyalgia
  • \-Predictably non\-compliant due to language barrier or psychiatric disease
  • \-Patients rescheduled for open surgery, before the intervention has been administered
  • \-Patients where the indication for surgery changes before the intervention has been administered
  • \-Patients with known inflammatory bowel disease
  • \-Patients who have previously undergone open major abdominal surgery defined by prior intraabdominal surgery with a midline or upper abdominal incision of more than 8 cm

Outcomes

Primary Outcomes

Not specified

Similar Trials